In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...
Nat Geo Explorer Zeb Hogan has spent decades asking the question. “I thought there would be a simple answer,” he now concedes, after recording a 661-pound stingray. “I was wrong.” Scientists tag and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback